Quantcast

Latest conjunctivitis Stories

2009-11-09 06:30:00

MIAMI, Nov. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced additional results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies.

2009-09-08 18:45:00

IRVINE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S.

2009-08-11 09:00:00

ATLANTA, Aug. 11 /PRNewswire/ -- MinuteClinic, the pioneer and largest provider of retail-based health care in the United States, is now offering a first-of-its kind rapid conjunctivitis (pink-eye) test at its 23 locations inside select CVS/pharmacy stores in the Atlanta area.

2009-07-05 17:00:00

EMERYVILLE, Calif. and HUENENBERG, Switzerland, July 5 /PRNewswire-FirstCall/ -- Alcon, Inc. (NYSE: ACL) and its partner, NovaBay Pharmaceuticals, Inc.

2009-06-26 09:28:00

IRVINE, Calif., June 26 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the U.S.

2009-05-29 07:15:00

- Besivance Adds to Bausch & Lomb's Expanding Ocular Pharmaceuticals Portfolio and Offers New Therapeutic Option for a Wide Range of Ocular Bacterial Pathogens(1) - MADISON, N.J., May 29 /PRNewswire/ -- Bausch & Lomb, a world leader in eye health, today announced that the U.S.

2009-05-28 15:05:30

The U.S.

2009-05-04 02:00:00

PARIS, May 4 /PRNewswire/ -- Fovea Pharmaceuticals announced today positive results from its clinical proof-of-concept trial to assess the therapeutic effect of Prednisporin(TM) (FOV1101) in patients with persistent allergic conjunctivitis. Prednisporin(TM) had the same efficacy and a better safety profile (no increase in intra-ocular pressure) than PredForte(TM), a prescription drug with a 10 fold higher dose of prednisolone acetate, in patients treated for the signs and symptoms (itching...

2009-01-15 06:30:00

IRVINE, Calif., Jan. 15 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced that ISTA's New Drug Application (NDA) for Bepreve(TM) (bepotastine ophthalmic solution) has been accepted for review by the U.S. Food and Drug Administration (FDA).

2008-12-16 07:00:00

HARBIN, China, Dec. 16 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc.


Word of the Day
lahar
  • A volcanic mudflow.
The word 'lahar' comes from Javanese.
Related